• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

What's the deal with Friday's confrence call??

Quote












My top guesses:
1) Expansion coming for mono therapy launch, 2 reps per territory so we can have more reps to see all these neuros with no access. But hey, at least then our call average will match the oncology team!
2) To announce the successful tweaking of Fycompa's molecule resulting in a new compound and imminent NDA for a "new chemical entity" called esli-ampanel.
3) New combo coming between Banzel and Onfi with brand name Banfi.
4) New Addition to Fycompa's boxed warning - bacteriocidal ideation. Makes you want to wash your hands 400 times a day.
5) To announce that just before Banzel goes generic we will be launching Banzel 223 and 423mg.
 








anonymous said:
My top guesses:
1) Expansion coming for mono therapy launch, 2 reps per territory so we can have more reps to see all these neuros with no access. But hey, at least then our call average will match the oncology team!
2) To announce the successful tweaking of Fycompa's molecule resulting in a new compound and imminent NDA for a "new chemical entity" called esli-ampanel.
3) New combo coming between Banzel and Onfi with brand name Banfi.
4) New Addition to Fycompa's boxed warning - bacteriocidal ideation. Makes you want to wash your hands 400 times a day.
5) To announce that just before Banzel goes generic we will be launching Banzel 223 and 423mg.
Click to expand...
6) To announce that compliance czar Shauna will be taking a leave of absence as President Trump intends to appoint her Special Prosecutor to investigate the Russian Hacking scandal.
7) To announce the addition of bacteriocidal-homicidal ideation to the boxed warning. Makes you want to wash your hands just before you grab that knife and stab someone in the back.
 




anonymous said:
6) To announce that compliance czar Shauna will be taking a leave of absence as President Trump intends to appoint her Special Prosecutor to investigate the Russian Hacking scandal.
7) To announce the addition of bacteriocidal-homicidal ideation to the boxed warning. Makes you want to wash your hands just before you grab that knife and stab someone in the back.
Click to expand...
8) Webex is to layout precise instructions on how to disarm the lane departure warning in your new Subaru if it drives you fucking crazy.
 




anonymous said:
My top guesses:
1) Expansion coming for mono therapy launch, 2 reps per territory so we can have more reps to see all these neuros with no access. But hey, at least then our call average will match the oncology team!
2) To announce the successful tweaking of Fycompa's molecule resulting in a new compound and imminent NDA for a "new chemical entity" called esli-ampanel.
3) New combo coming between Banzel and Onfi with brand name Banfi.
4) New Addition to Fycompa's boxed warning - bacteriocidal ideation. Makes you want to wash your hands 400 times a day.
5) To announce that just before Banzel goes generic we will be launching Banzel 223 and 423mg.
Click to expand...
 
































Crazy to think that everyone in epilepsy is currently in limbo. 4 DM's displaced and everyone unsure if they will have a job in 10 days. I've never seen a downsizing this brutal and without explanation of what is coming.
 




anonymous said:
Crazy to think that everyone in epilepsy is currently in limbo. 4 DM's displaced and everyone unsure if they will have a job in 10 days. I've never seen a downsizing this brutal and without explanation of what is coming.
Click to expand...
When you're viewed as a lower life form by the inscrutable do you really expect explanation for severe downsizing ?
 








What a way to layoff good employees.

- Set insanely high goals that destroy morale. All while wrapping yourself in the HHC flag of wanting to put patients first.

- Cram the Challenger sales model in place even though its better suited to B2B sales and does not fit well in traditional pharmaceutical sales much less in the neuro landscape.

- Adjust goals downward a bit to appear you are listening to employees while you're actually just buying time until the end of FY2016 to implement the new sales model.

- Create a new position giving it a fancy name to imply its bigger and badder. Wow I can be a NICM - Neuro Integrated Care Manager which is nothing more than a hospital rep.

- Make the qualifications so high that none of the current MSS's or field trainers can even apply. Note that Challenger conveniently fits the new sales model.

- Layoff 35 current reps and then bring in 23 NICM reps that are more expensive.

- Then sit back and watch how Fycompa growth remains the same because homicidal ideation, levetiracetam, Briviact, and Aptiom are still in the market.

- If the current national sales management truly cared about HHC and Eisai employees they could have simply initiated new training for the respective representatives with epilepsy units in their territories. This would have been a golden chance for employee development and given field trainers a solid chance at promotion without waiting for DSM openings.

- Unfortunately the rumors that have swirling since the hiring of a new sales director and 2 region directors have come to fruition - Eisai neuro reps are not competent and it is their fault Fycompa has not taken off like the Wall Street analysts had hoped.
 








Top Bottom
Back
Quote